Your browser doesn't support javascript.
loading
DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissues.
Zhang, Shirong; He, Shutao; Zhu, Xin; Wang, Yunfei; Xie, Qionghuan; Song, Xianrang; Xu, Chunwei; Wang, Wenxian; Xing, Ligang; Xia, Chengqing; Wang, Qian; Li, Wenfeng; Zhang, Xiaochen; Yu, Jinming; Ma, Shenglin; Shi, Jiantao; Gu, Hongcang.
Afiliação
  • Zhang S; Translational Medicine Research Center, Hangzhou First People's Hospital, 310006, Hangzhou, Zhejiang Province, China.
  • He S; Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Hangzhou First People's Hospital, 310006, Hangzhou, Zhejiang Province, China.
  • Zhu X; State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, 200031, Shanghai, China.
  • Wang Y; Institute of Biotechnology and Health, Beijing Academy of Science and Technology, 100089, Beijing, China.
  • Xie Q; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Zhejiang Cancer Hospital, 310022, Hangzhou, Zhejiang Province, China.
  • Song X; Zhejiang ShengTing Biotech Co. Ltd, 310018, Hangzhou, Zhejiang Province, China.
  • Xu C; Zhejiang ShengTing Biotech Co. Ltd, 310018, Hangzhou, Zhejiang Province, China.
  • Wang W; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China.
  • Xing L; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, 210002, Nanjing, Jiangshu Province, China.
  • Xia C; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Zhejiang Cancer Hospital, 310022, Hangzhou, Zhejiang Province, China.
  • Wang Q; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China.
  • Li W; Zhejiang ShengTing Biotech Co. Ltd, 310018, Hangzhou, Zhejiang Province, China.
  • Zhang X; Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, 210029, Nanjing, Jiangshu Province, China.
  • Yu J; Department of Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, 325000, Wenzhou, Zhejiang Province, China.
  • Ma S; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, 310006, Hangzhou, Zhejiang Province, China.
  • Shi J; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China.
  • Gu H; Translational Medicine Research Center, Hangzhou First People's Hospital, 310006, Hangzhou, Zhejiang Province, China. mashenglin@medmail.com.cn.
Nat Commun ; 14(1): 5686, 2023 09 14.
Article em En | MEDLINE | ID: mdl-37709764
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Primárias Desconhecidas / Segunda Neoplasia Primária Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Primárias Desconhecidas / Segunda Neoplasia Primária Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China